Production technologies for monoclonal antibodies and their fragments

Current Opinion in Biotechnology

Volumn 15, Issue 5, 2004, Pages 456-462

  Andersen, Dana C ^a   Reilly, Dorothea E ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLYCAN; IMMUNOGLOBULIN F(AB) FRAGMENT; MACROGOL; MONOCLONAL ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY PRODUCTION; CLINICAL TRIAL; DRUG HALF LIFE; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CELL PHYSIOLOGY; ESCHERICHIA COLI; FUNGI; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOTHERAPY; PLANTS;

MAMMALIA;

EID: 4644309963     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2004.08.002     Document Type: Review

References (67)

1. D.P. Humphreys, and D.J. Glover Therapeutic antibody production technologies: molecules, applications, expression and purification Curr Opin Drug Discov Dev 4 2001 172 185
2. D.P. Humphreys Production of antibodies and antibody fragments in Escherichia coli and a comparison of their functions, uses, modifications Curr Opin Drug Discov Dev 6 2003 188 196 A detailed overview of the different types of antibody fragments and their production in E. coli.
3. E.E. Hood, S.L. Woodard, and M.E. Horn Monoclonal antibody manufacturing in transgenic plants - myths and realities Curr Opin Biotechnol 13 2002 630 635
4. Roque ACA, C.R. Lowe, and M.A. Taipa Antibodies and genetically engineered related molecules: production and purification Biotechnol Prog 20 2004 639 654
5. C. Chen, B. Snedecor, J.C. Nishihara, J.C. Joly, N. Mcfarland, D.C. Andersen, J.E. Battersby, and K.M. Champion High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain Biotechnol Bioeng 85 2004 463 474
6. D.P. Humphreys, B. Carrington, L.C. Bowering, R. Ganesh, M. Sehdev, B.J. Smith, L.M. King, D.G. Reeks, A. Lawson, and A.G. Popplewell A plasmid system for optimization of Fab′ production in Escherichia coli: importance of balance of heavy chain and light chain synthesis Protein Expr Pur 26 2002 309 320
7. K. Ramm, and A. Plückthun The periplasmic Escherichia coli peptidylproyl cis, trans-isomerase FkpA J Biol Chem 275 2000 17106 17113
8. D.P. Humphreys, N. Weir, A. Lawson, A. Mountain, and P.A. Lund Co-expression of human protein disulphide isomerase (PDI) can increase the yield of an antibody Fab′ fragment expressed in Escherichia coli FEBS Lett 380 1996 194 197
9. A.P. Chapman, P. Antoniw, M. Spitali, S. West, S. Stephens, and D.J. King Therapeutic antibody fragments with prolonged in vivo half-lives Nat Biotechnol 17 1999 780 783
10. S.R. Leong, L. DeForge, L. Presta, T. Gonzalez, A. Fan, M. Reichert, A. Chuntharapai, K.J. Kim, D.B. Tumas, and W.P. Lee Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation Cytokine 16 2001 106 119
11. A.P. Chapman PEGylated antibodies and antibody fragments for improved therapy: a review Adv Drug Deliv Rev 54 2002 531 545
12. M.S. Dennis, M. Zhang, G. Meng, M. Kadkhodayan, D. Kirchhofer, D. Combs, and L.A. Damico Albumin binding as a general strategy for improving the pharmacokinetics of proteins J Biol Chem 277 2002 35035 35043 This report demonstrates the use of protein engineering to develop a novel peptide sequence that influences pharmacokinetics.
13. L.C. Simmons, D. Reilly, L. Klimowski, T.S. Raju, G. Meng, O. Sims, K. Hong, R.L. Shields, L.A. Damico, P. Rancatore, and D.G. Yansura Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies J Immunol Methods 263 2002 133 147 The first report of the production of functional full-length IgGs in E. coli.
14. A. Sotiriadis, T. Keshavarz, and E. Keshavarz-Moore Factors affecting the production of a single-chain antibody fragment by Aspergillus awamori in a stirred tank reactor Biotechnol Prog 17 2001 618 623
15. M. Ward, C. Lin, D.C. Victoria, B.P. Fox, J.A. Fox, D.L. Wong, H.J. Meerman, J.P. Pucci, R.B. Fong, and M.H. Heng Characterization of humanized antibodies secreted by Aspergillus niger Appl Environ Microbiol 70 2004 2567 2576 An interesting study on using A. niger for the production of antibodies and fragments.
16. S.R. Hamilton, P. Bobrowicz, B. Bobrowicz, R.C. Davidson, H. Li, T. Mitchell, J.H. Nett, S. Rausch, T.A. Stadheim, and H. Wischnewski Production of complex human glycoproteins in yeast Science 301 2003 1244 1246 This approach represents a powerful technique for host cell engineering to alter glycosylation of recombinant proteins.
17. F.M. Freyre, J.E. Vazquez, M. Ayala, L. Canaan-Haden, H. Bell, I. Rodriguez, A. Gonzalez, A. Cintado, and J.V. Gavilondo Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastoris J Biotechnol 76 2000 157 163
18. A.E. Cunha, J.J. Clemente, R. Gomes, F. Pinto, M. Thomaz, S. Miranda, R. Pinto, D. Moosmayer, P. Donner, and M.J.T. Carrondo Methanol induction optimization for scFv antibody fragment production in Pichia Pastoris Biotechnol Bioeng 86 2004 458 467
19. H. Bakker, M. Bardor, J.W. Molthoff, V. Gomord, I. Elbers, L.H. Stevens, W. Jordi, A. Lommen, L. Faye, P. Lerouge, and D. Bosch Galactose-extended glycans of antibodies produced by transgenic plants Proc Natl Acad Sci USA 98 2001 2899 2904
20. L. Xie, W. Pilbrough, C. Metallo, T. Zhong, L. Pikus, J. Leung, J. Aunins, and W. Zhou Serum-free suspension cultivation of PER.C6 cells and recombinant adenovirus production under different pH conditions Biotechnol Bioeng 80 2002 569 579
21. D. Jones, N. Kroos, R. Anema, B. van Montfort, A. Vooys, S. van der Kraats, E. van der Helm, S. Smits, J. Schouten, and K. Brouwer High-level expression of recombinant IgG in the human cell line PER.C6 Biotechnol Prog 19 2003 163 168
22. A.A. Bianchi, and J.T. McGrew High-level expression of full-length antibodies using trans-complementing expression vectors Biotechnol Bioeng 84 2003 439 444 An interesting approach to ensure co-amplification of heavy and light chains.
23. T.L. Aldrich, A. Viaje, and A.E. Morris EASE vectors for rapid stable expression of recombinant antibodies Biotechnol Prog 19 2003 1433 1438
24. D.C. Andersen, and L. Krummen Recombinant protein expression for therapeutic applications Curr Opin Biotechnol 13 2002 117 123
25. M. Fussenegger, J.E. Bailey, H. Hauser, and P.P. Mueller Genetic optimization of recombinant glycoprotein production by mammalian cells Trends Biotechnol 17 1999 35 42
26. L.M. Barnes, C.M. Bentley, and A.J. Dickson Stability of protein production from recombinant mammalian cells Biotechnol Bioeng 81 2003 631 639
27. N.S. Kim, T.H. Byun, and G.M. Lee Key determinants in the occurrence of clonal variation in humanized antibody expression of CHO cells during dihydrofolate reductase mediated gene amplification Biotechnol Prog 17 2001 69 75
28. S.C. Brezinsky, G.G. Chiang, A. Szilvasi, S. Mohan, R.I. Shapiro, A. Maclean, W. Sisk, and G. Thill A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity J Immunol Methods 277 2003 141 155
29. C.G. Bailey, A.S. Tait, and N.-A. Sunstrom High-throughput clonal selection of recombinant CHO cells using a dominant selectable and amplifiable metallothionein-GFP fusion protein Biotechnol Bioeng 80 2002 670 676
30. Borth N, Zeyda M, Katinger H: Efficient selection of high-producing subclones during gene amplification of recombinant Chinese hamster ovary cells by flow cytometry and cell sorting. Biotechnol Bioeng 2000-2001, 71:266-273.
31. H. Meents, B. Enenkel, R.G. Werner, and M. Fussenegger p27Kip1-mediated controlled proliferation technology increases constitutive sICAM production in CHO-DUKX adapted for growth in suspension and serum-free media Biotechnol Bioeng 79 2002 619 627
32. A.V. Carvahal, I. Marcelino, and M.J.T. Carrondo Metabolic changes during cell growth inhibition by p27 overexpression Appl Microbiol Biotechnol 63 2003 164 173
33. J.-X. Bi, J. Shuttleworth, and M. Al-Rubeai Uncoupling of cell growth and proliferation results in enhancement of productivity in p21cip1-arrested CHO cells Biotechnol Bioeng 85 2004 741 749
34. C. Altamirano, J.J. Cairo, and F. Godia Decoupling cell growth and product formation in Chinese hamster ovary cells through metabolic control Biotechnol Bioeng 76 2001 351 360
35. A.V. Carvahal, S. Sa Santos, J. Calado, M. Haury, and M.J.T. Carrondo Cell growth arrest by nucleotides, nucleosides and bases as a tool for improved production or recombinant proteins Biotechnol Prog 19 2003 69 83
36. I.H.Y. Yuk, S. Wildt, M. Jolicoeur, D.I.C. Wang, and G. Stephanopoulos A GFP-based screen for growth-arrested recombinant protein-producing cells Biotechnol Bioeng 79 2002 74 82
37. A.J. Mastrangelo, J.M. Hardwick, S. Zou, and M.J. Betenbaugh Part 2. Over-expression of bcl-2 family members enhances survival of mammalian cells in response to various culture insults Biotechnol Bioeng 67 2000 555 564
38. L enhance protection against apoptosis for mammalian cells exposed to various culture conditions Biotechnol Bioeng 85 2004 589 600
39. T.M. Sauerwald, G.A. Oyler, and M.J. Betenbaugh Study of caspase inhibitors for limiting cell death in mammalian cell culture Biotechnol Bioeng 81 2003 329 340
40. N.S. Kim, and G.M. Lee Inhibition of sodium butyrate-induced apoptosis in recombinant Chinese hamster ovary cells by constitutively expressing antisense RNA of caspase-3 Biotechnol Bioeng 78 2002 217 228
41. E.B. Lasunskaia, I.I. Fridlianskaia, Z.A. Darieva, da Silva MSR, M.M. Kanashiro, and B.A. Margulis Transfection of NS0 myeloma fusion partner cells with hsp70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis Biotechnol Bioeng 81 2003 496 504
42. S.K. Lee, and G.M. Lee Development of apoptosis-resistance dihydrofolate reductase-deficient Chinese hamster ovary cell line Biotechnol Bioeng 82 2003 872 876
43. L on productivity, cell survival, and mitochondrial number in CHO-DG44 grown in suspension and serum-free media Biotechnol Bioeng 80 2002 706 716
44. L restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures Biotechnol Bioeng 79 2002 180 187
45. N. Ibarra, S. Watanabe, J-X. Bi, J. Shuttleworth, and M. Al-Rubeai Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells Biotechnol Prog 19 2003 224 228 Combines growth control and anti-apoptosis engineering to enhance antibody productivity.
46. N. Lambert, and O.-W. Merten Effect of serum-free and serum-containing medium on cellular levels of ER-based proteins in various mouse hybridoma cell lines Biotechnol Bioeng 54 1997 165 180
47. J.Y. Chung, S.W. Lim, Y.J. Hong, S.O. Hwang, and G.M. Lee Effect of doxycycline-regulated calnexin and calreticulin expression on specific thrombopoietin productivity of recombinant Chinese hamster ovary cells Biotechnol Bioeng 89 2004 539 546
48. A. Wright, and S.L. Morrison Effect of glycosylation on antibody function: implications for genetic engineering Trends Biotechnol 15 1997 26 32
49. R. Jefferis Glycosylation of human IgG antibodies: relevance to therapeutic applications Biopharm 9 2001 19 27
50. R.L. Shields, J. Lai, R. Keck, L.Y. O'Connell, K. Hong, Y.G. Meng, S.H. Weikert, and L.G. Presta Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc-γ RIII and antibody-dependent cellular toxicity J Biol Chem 277 2002 26733 26740 Significant improvements in ADCC result from alteration of the oligosaccharides on Fc.
51. T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-Hosaka, Y. Kanda, M. Sakurada, K. Uchida, H. Anazawa, M. Satoh, and M. Yamasaki The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxity J Biol Chem 278 2003 3466 3473
52. L.G. Presta, R.L. Shields, A.K. Namenuk, K. Hong, and Y.G. Meng Engineering therapeutic antibodies for improved function Biochem Soc Trans 30 2002 487 490
53. P.R. Hinton, M.G. Johlfs, J.M. Xiong, K. Hanestad, K.C. Ong, C. Bullock, S. Keller, M.T. Tang, J.Y. Tso, M. Vasquez, and N. Tsurushita Engineered human IgG antibodies with longer serum half-lives in primates J Biol Chem 279 2004 6213 6216
54. J.J. Osman, J. Birch, and J. Varley The response of GS-NS0 myeloma cells to single and multiple pH perturbations Biotechnol Bioeng 79 2003 398 407
55. 2 and osmolality: intracellular pH, cell size, apoptosis, and metabolism Biotechnol Bioeng 77 2002 369 380
56. 2 alter monoclonal antibody charge distribution and monosaccharide content Biotechnol Prog 18 2002 346 353
57. V.M. DeZengotita, L.R. Abston, A.E. Schmelzer, S. Shaw, and W.M. Miller Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality Biotechnol Bioeng 78 2002 741 752
58. Z. Sun, R. Zhou, S. Liang, K.M. McNeeley, and S.T. Sharfstein Hyperosmotic stress in murine hybridoma cells: effects on antibody transcription, translation, posttranslational processing and the cell cycle Biotechnol Prog 20 2004 576 589
59. J. Muthing, S.E. Kemminer, H.S. Conradt, D. Sagi, M. Nimtz, U. Karst, and J. Peter-Katalinic Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24 Biotechnol Bioeng 83 2003 321 334
60. J.S. Ryu, M.S. Lee, and G.M. Lee Effects of cloned gene dosage on the response of recombinant CHO cells to hyperosmotic pressure in regard to cell growth and antibody production Biotechnol Prog 17 2001 993 999
61. M.S. Lee, K.W. Kim, Y.H. Kim, and G.M. Lee Proteome analysis of antibody-expressing CHO cells in response to hyperosmotic pressure Biotechnol Prog 19 2003 1734 1741
62. S.K. Yoon, S.H. Kim, and G.M. Lee Effect of low temperature on specific productivity and transcription level of anti-4-BB antibody in recombinant Chinese hamster ovary cells Biotechnol Prog 19 2003 1383 1386
63. S.K. Yoon, J.Y. Song, and G.M. Lee Effect of low temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells Biotechnol Bioeng 82 2003 289 298
64. S.M. Schatz, R.J. Kerschbaumer, G. Gerstenbauer, M. Kral, F. Dorner, and F. Scheiflinger Higher expression of Fab antibody fragments in a CHO cell line at reduced temperature Biotechnol Bioeng 84 2003 433 438
65. S.R. Fox, U.A. Patel, M.G.S. Yap, and D.I.C. Wang Maximizing interferon-γ production by Chinese hamster ovary cells through temperature shift optimization: experimental and modeling Biotechnol Bioeng 85 2004 177 184
66. F. Franek, T. Eckschlager, and H. Katinger Enhancement of monoclonal antibody production by lysine-containing peptides Biotechnol Prog 19 2003 169 174
67. M.J. Gramer, and T.L. Britton Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms Biotechnol Bioeng 79 2002 277 283